Clinical Trial Update: A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis) [Phase 2]

View source ↗

Summary

A Phase 2 study to evaluate the efficacy of GX-03 in moderate-to-severe atopic dermatitis (eczema) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• GX-03

Snippet

Sponsor: Turn Therapeutics | Conditions: Eczema Atopic Dermatitis, Eczema | Phase 2 | Status: RECRUITING